187 related articles for article (PubMed ID: 32464217)
1. CRISPR/Cas9-mediated metabolic pathway reprogramming in a novel humanized rat model ameliorates primary hyperoxaluria type 1.
Zheng R; Li Y; Wang L; Fang X; Zhang J; He L; Yang L; Li D; Geng H
Kidney Int; 2020 Oct; 98(4):947-957. PubMed ID: 32464217
[TBL] [Abstract][Full Text] [Related]
2. Generation and characterization of a novel rat model of primary hyperoxaluria type 1 with a nonsense mutation in alanine-glyoxylate aminotransferase gene.
Li Y; Zheng R; Xu G; Huang Y; Li Y; Li D; Geng H
Am J Physiol Renal Physiol; 2021 Mar; 320(3):F475-F484. PubMed ID: 33491567
[TBL] [Abstract][Full Text] [Related]
3. Generation of a Primary Hyperoxaluria Type 1 Disease Model Via CRISPR/Cas9 System in Rats.
Zheng R; Fang X; He L; Shao Y; Guo N; Wang L; Liu M; Li D; Geng H
Curr Mol Med; 2018; 18(7):436-447. PubMed ID: 30539697
[TBL] [Abstract][Full Text] [Related]
4. In vivo base editing rescues primary hyperoxaluria type 1 in rats.
Chen Z; Zhang D; Zheng R; Yang L; Huo Y; Zhang D; Fang X; Li Y; Xu G; Li D; Geng H
Kidney Int; 2024 Mar; 105(3):496-507. PubMed ID: 38142039
[TBL] [Abstract][Full Text] [Related]
5. Targeted gene therapy in human-induced pluripotent stem cells from a patient with primary hyperoxaluria type 1 using CRISPR/Cas9 technology.
Estève J; Blouin JM; Lalanne M; Azzi-Martin L; Dubus P; Bidet A; Harambat J; Llanas B; Moranvillier I; Bedel A; Moreau-Gaudry F; Richard E
Biochem Biophys Res Commun; 2019 Oct; 517(4):677-683. PubMed ID: 31402115
[TBL] [Abstract][Full Text] [Related]
6. Phenotypic correction of a mouse model for primary hyperoxaluria with adeno-associated virus gene transfer.
Salido E; Rodriguez-Pena M; Santana A; Beattie SG; Petry H; Torres A
Mol Ther; 2011 May; 19(5):870-5. PubMed ID: 21119625
[TBL] [Abstract][Full Text] [Related]
7. Systemic Alanine Glyoxylate Aminotransferase mRNA Improves Glyoxylate Metabolism in a Mouse Model of Primary Hyperoxaluria Type 1.
Kukreja A; Lasaro M; Cobaugh C; Forbes C; Tang JP; Gao X; Martin-Higueras C; Pey AL; Salido E; Sobolov S; Subramanian RR
Nucleic Acid Ther; 2019 Apr; 29(2):104-113. PubMed ID: 30676254
[TBL] [Abstract][Full Text] [Related]
8. Re: CRISPR/Cas9-Mediated Metabolic Pathway Reprogramming in a Novel Humanized Rat Model Ameliorates Primary Hyperoxaluria Type 1.
Assimos DG
J Urol; 2020 Nov; 204(5):1092. PubMed ID: 32821003
[No Abstract] [Full Text] [Related]
9. Multiplex gene editing reduces oxalate production in primary hyperoxaluria type 1.
Zheng R; Zhang DX; Shao YJ; Fang XL; Yang L; Huo YN; Li DL; Geng HQ
Zool Res; 2023 Nov; 44(6):993-1002. PubMed ID: 37759334
[TBL] [Abstract][Full Text] [Related]
10. Alanine-glyoxylate aminotransferase-deficient mice, a model for primary hyperoxaluria that responds to adenoviral gene transfer.
Salido EC; Li XM; Lu Y; Wang X; Santana A; Roy-Chowdhury N; Torres A; Shapiro LJ; Roy-Chowdhury J
Proc Natl Acad Sci U S A; 2006 Nov; 103(48):18249-54. PubMed ID: 17110443
[TBL] [Abstract][Full Text] [Related]
11. CRISPR/Cas9-mediated glycolate oxidase disruption is an efficacious and safe treatment for primary hyperoxaluria type I.
Zabaleta N; Barberia M; Martin-Higueras C; Zapata-Linares N; Betancor I; Rodriguez S; Martinez-Turrillas R; Torella L; Vales A; Olagüe C; Vilas-Zornoza A; Castro-Labrador L; Lara-Astiaso D; Prosper F; Salido E; Gonzalez-Aseguinolaza G; Rodriguez-Madoz JR
Nat Commun; 2018 Dec; 9(1):5454. PubMed ID: 30575740
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of Glycolate Oxidase With Dicer-substrate siRNA Reduces Calcium Oxalate Deposition in a Mouse Model of Primary Hyperoxaluria Type 1.
Dutta C; Avitahl-Curtis N; Pursell N; Larsson Cohen M; Holmes B; Diwanji R; Zhou W; Apponi L; Koser M; Ying B; Chen D; Shui X; Saxena U; Cyr WA; Shah A; Nazef N; Wang W; Abrams M; Dudek H; Salido E; Brown BD; Lai C
Mol Ther; 2016 Apr; 24(4):770-8. PubMed ID: 26758691
[TBL] [Abstract][Full Text] [Related]
13. Differential expression of liver and kidney proteins in a mouse model for primary hyperoxaluria type I.
Hernández-Fernaud JR; Salido E
FEBS J; 2010 Nov; 277(22):4766-74. PubMed ID: 20977670
[TBL] [Abstract][Full Text] [Related]
14. Knockdown of lactate dehydrogenase by adeno-associated virus-delivered CRISPR/Cas9 system alleviates primary hyperoxaluria type 1.
Zheng R; Fang X; Chen X; Huang Y; Xu G; He L; Li Y; Niu X; Yang L; Wang L; Li D; Geng H
Clin Transl Med; 2020 Dec; 10(8):e261. PubMed ID: 33377632
[TBL] [Abstract][Full Text] [Related]
15. [From gene to disease; primary hyperoxaluria type I caused by mutations in the AGXT gene].
van Woerden CS; Groothof JW; Wanders RJ; Waterham HR; Wijburg FR
Ned Tijdschr Geneeskd; 2006 Jul; 150(30):1669-72. PubMed ID: 16922352
[TBL] [Abstract][Full Text] [Related]
16. An Investigational RNAi Therapeutic Targeting Glycolate Oxidase Reduces Oxalate Production in Models of Primary Hyperoxaluria.
Liebow A; Li X; Racie T; Hettinger J; Bettencourt BR; Najafian N; Haslett P; Fitzgerald K; Holmes RP; Erbe D; Querbes W; Knight J
J Am Soc Nephrol; 2017 Feb; 28(2):494-503. PubMed ID: 27432743
[TBL] [Abstract][Full Text] [Related]
17. Primary hyperoxaluria in a compound heterozygote infant.
Mayordomo-Colunga J; Riverol D; Salido E; Santos F
World J Pediatr; 2011 May; 7(2):173-5. PubMed ID: 20549407
[TBL] [Abstract][Full Text] [Related]
18. Identification of compound heterozygous patients with primary hyperoxaluria type 1: clinical evaluations and in silico investigations.
Kanoun H; Jarraya F; Maalej B; Lahiani A; Mahfoudh H; Makni F; Hachicha J; Fakhfakh F
BMC Nephrol; 2017 Oct; 18(1):303. PubMed ID: 28969594
[TBL] [Abstract][Full Text] [Related]
19. Identification of a novel AGXT gene mutation in primary hyperoxaluria after kidney transplantation failure.
M'dimegh S; Omezzine A; Hamida-Rebai MB; Aquaviva-Bourdain C; M'barek I; Sahtout W; Zellama D; Souche G; Achour A; Abroug S; Bouslama A
Transpl Immunol; 2016 Nov; 39():60-65. PubMed ID: 27568336
[TBL] [Abstract][Full Text] [Related]
20. Correction of hyperoxaluria by liver repopulation with hepatocytes in a mouse model of primary hyperoxaluria type-1.
Jiang J; Salido EC; Guha C; Wang X; Moitra R; Liu L; Roy-Chowdhury J; Roy-Chowdhury N
Transplantation; 2008 May; 85(9):1253-60. PubMed ID: 18475180
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
